Rapid Micro Biosystems (RPID) Other financing activities (2020 - 2021)
Rapid Micro Biosystems recorded quarterly Other financing activities of $1.5 million in Q2 2021, down 43.26% quarter-over-quarter from $2.7 million in Q1 2021, and up 496.11% year-over-year from $257000.0 in Q2 2020.
Rapid Micro Biosystems' Other financing activities history runs 2 years deep, the most recent figure standing at $1.5 million for Q2 2021.
- In Q2 2021, Other financing activities rose 496.11% year-over-year to $1.5 million; the TTM figure through Dec 2025 stood at $4.2 million (changed 0.42% YoY), while the FY2025 annual figure was $878000.0, changed N/A from the prior year.
- Other financing activities came in at $1.5 million for Q2 2021 at Rapid Micro Biosystems, down from $2.7 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $2.7 million in Q1 2021 to a low of $18000.0 in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Rapid Micro Biosystems | 89.50 Mn | 66.56 Mn | 371,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 1.53 Mn |
| Jun 30, 2021 | 1.53 Mn |
| Mar 31, 2021 | 2.70 Mn |
| Mar 31, 2021 | 2.70 Mn |
| Dec 31, 2020 | 18,000.00 |
| Dec 31, 2020 | 18,000.00 |
| Jun 30, 2020 | 257,000.00 |
| Jun 30, 2020 | 257,000.00 |